[1] Arbyn M,Castellsague X,Bruni L,et al. Worldwide burden of cervical cancer in 2008[J]. Ann Oncol,2011,22:2675-2686. [2] Abudukadeer A,Azam S,Mutailipu AZ,et al. Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and eraly detection of cervical cancer[J]. World J Surg Oncol,2015,13:110. [3] Min A,Zhu C,Peng S,et al. MicroRNAs as important players and biomarkers in oral carcinogenesis[J]. Biomed Res Int,2015,10(4):1155-1165. [4] Gilabert-Estelles J,Braza-Boils A,Ramon LA,et al. Role of microRNAs in gynecological pathology[J]. Curr Med Chem 2012,19(15):2406-2413. [5] Weng WH,Wang ML,Xie SH,et al. YY1-C/EBPα-miR-34a regulatory circuitry is involved in renal cell carcinoma progression[J]. Oncology Reports,2014,31(4):1921-1927. [6] He L,He X,Lim LP,et al. A microRNA component of the p53 tumour suppressor network[J]. Nature,2007,447(7148): 1130-1134. [7] Peiretti M,Zapardiel I,Zanagnolo V,et al. Management of recurrent cervical cancer:a review of the literature[J]. Surg Oncol,2012,21:59-66. [8] Gardiner AS,McBee WC,Edwards RP,et al. MicroRNA analysis in human papillpmavirus (HPV)-associated cervical neoplasia and cancer[J]. Infect Agent Cancer,2010,5(1): A55. [9] Pereira PM,Marques JP,Soares AR,et al. MicroRNA expression variability in hunman cervical tissues[J]. PLoS One,2010,5(7):e11780. [10] Rao Q,Shen Q,Zhou H,et al. Aberrant microRNA expression in hunman cervical carcinomas[J]. Med Oncol 2012,29(2):1242-1248. [11] Suzuki HI,Yamagata K,Sugimoto K,et al. Modulation of microRNA processing by p53[J]. Nature,2009,60(4):529-533. [12] JIN Hua,MA Xiang-yu,GUO Xia,et al. Expressions and significance of HER-2,MMP-2,IGF-1 and VEGF in cervical cancer[J]. Carcinog Teratog Mutag,2014,26(6):446-448. [13] Chakraborty S,Mazumdar M,Mukherjee S,et al. Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells[J]. FEBS Lett,2014,588(4):549-559. [14] Sharma N,Timmers C,Trikha P,et al. Control of the p53-p21CIP1 Axis by E2f1,E2f2,and E2f3 is essential for G1/S progression and cellular transformation[J]. J Biol Chem,2006 281(47):36124-36131. [15] Luzhna L,Kovalchuk O. Low dose irradiation profoundly affects transcriptome and microRNAme in rat mammary gland tissues[J]. Oncoscience,2014,1(11):751-762. [16] Herbert KJ,Cook AL,Snow ET. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated hunman keratinocytes[J]. Toxicol Appl Pharmacol,2014,277(3):288-297. [17] Osawa S,Shimada Y,Sekine S,et al. MicroRNA profiling of gastric cancer patients from formalin-fixed paraffinembedded samples[J]. Oncol Lett,2011,2(4):613-619. [18] Andersen M,Grauslund M,Ravn J,et al. Diagnostic potential of miR-126,miR-143,miR-145,and miR-652 in malig-nant pleural mesothelioma[J]. J Mol Diagn,2014 16(4):418-430. [19] Wang JB,Wang QW,Liu H. The association of miR-146a rs2910164 and miR-196a2 rs1161- 4913 polymorphisms with cancer risk:a meta-analysis of 32 studies[J]. Mutagenesis 2012,27(6):779-788. [20] Hall JS,Taylor J,Valentine HR,et al. Enhanced stability of microRNA expression facilitates classification of FFPE tumor samples exhibiting near total mRNA degradation[J]. Br J Cancer,2012,107(4):684-694. |